Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer

✍ Scribed by Hohaus, S; Funk, L; Martin, S; Schlenk, R F; Abdallah, A; Hahn, U; Egerer, G; Goldschmidt, H; Schneeweiß, A; Fersis, N

• Book ID: 110001101
• Publisher: Nature Publishing Group
• Year: 1999
• Tongue: English
• Weight: 135 KB
• Volume: 79
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6690239